The Diabetes Impact Forum, organized by Laketown Synergy, concluded successfully on 1st December 2024 at the prestigious Taj Hotel in Kolkata. This groundbreaking event brought together leading medical experts, healthcare professionals, and stakeholders to discuss the latest advancements, challenges, and innovations in diabetes management. With a focus on insulin innovation, digital health technology, and patient-centric care, the forum served as a platform for knowledge exchange and collaboration, aiming to transform the landscape of diabetes treatment in India and beyond. The event underscored the importance of adopting cutting-edge solutions while addressing the barriers to insulin adoption and improving patient outcomes.
The forum featured an impressive lineup of sessions led by renowned experts in the field. Dr. Samar Banerjee and Dr. Soumyabrata Roy Chaudhuri kicked off the discussions with an insightful symposium on insulin innovation, followed by Dr. Rana Bhattacharya’s presentation on advancements in basal insulins. Dr. Tirthankar Chaudhury highlighted the transformative role of digital health technology in managing Type 2 Diabetes (T2D), while Dr. Sekhar Chakraborty and Dr. Subir Ray led a compelling panel discussion on optimizing basal insulin therapy. The event also explored emerging parameters in blood glucose control, offering a comprehensive view of the future of diabetes care. Each session was meticulously designed to address critical gaps in diabetes management and inspire actionable solutions.
Laketown Synergy extends its heartfelt gratitude to all the participating doctors, patients, sponsors, and organizers who made the Diabetes Impact Forum 2024 a resounding success. Special thanks to the esteemed speakers for sharing their expertise and to the attendees for their active engagement and valuable contributions. We also acknowledge the unwavering support of our sponsors, whose commitment to advancing diabetes care played a pivotal role in bringing this event to life. Together, we have taken a significant step forward in the fight against diabetes, and we look forward to continuing this journey of innovation, collaboration, and impact.
